Daru 18(3):155162 Chatterjee S (2016) Oxidative stress, inflammation, and disease
Medication is billed quarterly at ~$837 per 3-month supply for brand-name GLP-1s, the payment shock our audience flags most often
They found significantly fewer new acetazolamide prescriptions in the GLP-1 RA group (exenatide, lixisenatide, semaglutide, dulaglutide, liraglutide, tirzepatide) compared to controls [37]
[2] Dulaglutide (Trulicity), another once-weekly injectable GLP-1 agonist, demonstrates a somewhat more favourable gastrointestinal tolerability profile in some studies, with nausea reported in approximately 8-12% of patients at lower doses, though rates increase with higher doses (3
It comes from clinical experience, lab work, and watching what actually keeps post-op patients healthy long-term